| Indicator Name | % of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine |
|---|---|
| Indicator ID in PRIME | IN00041508 |
Definition
| Definition | This indicator measures the percentage of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine. |
|---|---|
| Numerator | Number of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine |
| Denominator | Total number of children aged 12-23 months in the target group for each vaccine |
Recommended Means of Verification
There are two ways to measure this indicator.
(1) Looking at the following data sources for:
Numerator: program/project records, health facility immunization records, or national/sub-regional HMIS/DHIS.
Denominator: the country's national/sub-regional population estimates for the SC program/project intervention areas.
(2) Conducting individual interviews with a representative sample of mothers or caregivers of children aged 12-23 months, inquiring if their children received the third dose of DTP/Hep B/PCV/Hib/Rotavirus vaccine in the last specified time period. This information can be gathered via:
a) Vaccination Card:
Do you have a card or other document where [name]'s vaccinations are written down?
Did you ever have a vaccination card for [name]?
Record vaccination dates from the vaccination card in a checklist containing the list of DTP/Hep B/PCV/Hib/Rotavirus vaccines with their respective doses 1,2,3.
Take note of the number of children who received third doses.
or
b) Mother's report to the following questions:
Has [name] ever received a [DTP/Hep B/PCV/Hib/Rotavirus] vaccine, that is, [brief explanation of purpose of vaccination]?
If yes, how many times did [name] receive the [DTP/Hep B/PCV/Hib/Rotavirus] vaccine?
To calculate the indicator's value, divide the number of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine by the total number of children aged 12-23 months in the target group for each vaccine. Multiply the result by 100 to convert it to a percentage.
For the dosage of these vaccines to be valid, vaccinations need to be administered within 28 days of each other.
Indicator Attributes
| Indicator Prioritisation | Global Indicator |
|---|---|
| Level of Indicator | Outcome |
| Indicator Context Type | Quantitative |
| Theme | Health & Nutrition |
| Sub Theme | Child Health |
| Common Approach | Treating Children Close to Home (Integrated Community Case Management) |
| Context | Development |
Measurement Guidance
| Frequency of Data Collection | Annually |
|---|---|
| Unit of Measure | Individual |
| Data Format | Percent |
| Direction of Desired Change | Increasing |
| Number of Decimal Points | Zero |
| Nature | Cumulative |
| Recommended Disaggregations | Gender |
Tools
Do you have a card or other document where [name]'s vaccinations are written down?
Did you ever have a vaccination card for [name]?
Has [name] ever receive a [DTP/Hep B/PCV/Hib/Rotavirus] vaccine, that is, [brief explanation of purpose of vaccination]?
If yes, how many times did [name] receive the [DTP/Hep B/PCV/Hib/Rotavirus] vaccine?
DHS8 Model Woman's Questionnaire: question 502-509; 523-528
https://dhsprogram.com/pubs/pdf/DHSQ8/DHS8_Womans_QRE_EN_14Feb2023_DHSQ8.pdf
DHS Guide:
https://dhsprogram.com/data/Guide-to-DHS-Statistics/Vaccination.htm